Adaptis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAPTIS, and what generic and branded alternatives to ADAPTIS drugs are available?
ADAPTIS has four approved drugs.
Drugs and US Patents for Adaptis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-001 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | VALACYCLOVIR HYDROCHLORIDE | valacyclovir hydrochloride | TABLET;ORAL | 079012-002 | May 24, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-006 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |